Petlife Pharmaceuticals, Inc.
PTLF
$0.0001
$0.000.00%
| 02/28/2018 | 11/30/2017 | 08/31/2017 | 05/31/2017 | 02/28/2017 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.90K | 54.30K | 54.30K | 300.00 | 400.00 |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | 17.90K | -- |
| Prepaid Expenses | -- | 3.30K | 800.00 | -- | 212.90K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 7.90K | 57.60K | 55.00K | 18.20K | 213.40K |
|
|
|||||
| Total Current Assets | 7.90K | 57.60K | 55.00K | 18.20K | 213.40K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | 252.10K | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 7.90K | 57.60K | 55.00K | 270.30K | 213.40K |
|
|
|||||
| Total Accounts Payable | 297.10K | 370.10K | 377.50K | 335.90K | 370.30K |
| Total Accrued Expenses | 286.90K | 246.90K | 229.40K | 401.60K | 353.80K |
| Short-term Debt | 801.70K | 755.40K | 717.20K | 844.90K | 401.70K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 595.40K | 457.60K | 112.40K | 10.00K | -- |
| Total Other Current Liabilities | 595.40K | 457.60K | 112.40K | 10.00K | -- |
| Total Current Liabilities | 1.98M | 1.83M | 1.44M | 1.59M | 1.13M |
|
|
|||||
| Total Current Liabilities | 1.98M | 1.83M | 1.44M | 1.59M | 1.13M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 801.70K | 755.40K | 717.20K | 844.90K | 401.70K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.98M | 1.83M | 1.44M | 1.59M | 1.13M |
|
|
|||||
| Common Stock & APIC | 29.31M | 29.08M | 29.00M | 27.07M | 26.66M |
| Retained Earnings | -31.28M | -30.85M | -30.39M | -28.39M | -27.57M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -1.98M | -1.78M | -1.38M | -1.32M | -912.40K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 3.30K | 3.30K | 3.30K | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 3.30K | 3.30K | 3.30K | -- | -- |
|
|
|||||
| Total Common Equity | -1.98M | -1.78M | -1.38M | -1.32M | -912.40K |
| Total Preferred Equity | 3.30K | 3.30K | 3.30K | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.97M | -1.77M | -1.38M | -1.32M | -912.40K |
|
|
|||||
